| Literature DB >> 24195063 |
Fei Dong1, Zhi-Bin Ji, Cun-Xian Chen, Gui-Zhi Wang, Jian-Min Wang.
Abstract
MicroRNAs are small noncoding RNAs that can regulate gene expression, and they can be involved in the regulation of mammary gland development. The differential expression of miRNAs during mammary gland development is expected to provide insight into their roles in regulating the homeostasis of mammary gland tissues. To screen out miRNAs that should have important regulatory function in the development of mammary gland from miRNA expression profiles and to predict their function, in this study, the target genes of differentially expressed miRNAs in the lactating mammary glands of Laoshan dairy goats are predicted, and then the functions of these miRNAs are analyzed via bioinformatics. First, we screen the expression patterns of 25 miRNAs that had shown significant differences during the different lactation stages in the mammary gland. Then, these miRNAs are clustered according to their expression patterns. Computational methods were used to obtain 215 target genes for 22 of these miRNAs. Combining gene ontology annotation, Fisher's exact test, and KEGG analysis with the target prediction for these miRNAs, the regulatory functions of miRNAs belonging to different clusters are predicted.Entities:
Year: 2013 PMID: 24195063 PMCID: PMC3806118 DOI: 10.1155/2013/917342
Source DB: PubMed Journal: Int J Genomics ISSN: 2314-436X Impact factor: 2.326
Figure 1The expression patterns of 25 miRNAs belonging to five classifications. These miRNAs are clustered according to their expressions at three stages by SPSS 19.0. The three stages are early lactation (20 days postpartum), peak lactation (90 days postpartum), and late lactation (210 days postpartum). (a) The expression patterns of miRNAs that increase during these three stages. (b) The expression patterns of miRNAs that showed the lowest expression level at peak lactation. (c) The expression of miRNAs that showed a similar level at peak and late lactation but were higher than at early lactation. (d) The expression patterns of miRNAs that showed the highest level at peak lactation. (e) The expression patterns of miRNAs that showed a similar level at peak and late lactation but were lower than at early lactation.
The number of targets predicted by the eight prediction software.
| miRNA name | TargetScan | DIANA-microT | miRanda ( | miRanda (miRBase) | PicTar (4-way) | PicTar (5-way) | TargetscanS | PITA |
|---|---|---|---|---|---|---|---|---|
| bta-miR-29b | 962 | 15 | 993 | 304 | 527 | 145 | 602 | 941 |
| bta-miR-29c | 44 | 14 | 981 | 305 | 532 | 147 | 602 | 3344 |
| bta-miR-375 | 646 | 1 | 787 | 0 | 159 | 34 | 180 | 717 |
| bta-miR-135a | 610 | 15 | 930 | 0 | 327 | 108 | 397 | 2279 |
| bta-miR-22-5p | 252 | 10 | 751 | 206 | 258 | 71 | 252 | 1409 |
| bta-miR-885 | 184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| bta-miR-214 | 394 | 10 | 844 | 318 | 401 | 103 | 327 | 1936 |
| bta-miR-33a | 372 | 11 | 883 | 211 | 246 | 103 | 208 | 1555 |
| bta-miR-451 | 22 | 1 | 815 | 0 | 0 | 0 | 14 | 1971 |
| bta-miR-190a | 177 | 8 | 677 | 157 | 88 | 39 | 86 | 1696 |
| bta-miR-378 | 151 | 3 | 623 | 0 | 0 | 0 | 284 | 3400 |
| bta-miR-423-5p | 159 | 0 | 722 | 0 | 0 | 0 | 9 | 6161 |
| bta-miR-7 | 403 | 15 | 628 | 173 | 234 | 61 | 217 | 1793 |
| bta-miR-423-3p | 10 | 0 | 722 | 0 | 0 | 0 | 9 | 678 |
| bta-miR-99a | 18 | 0 | 772 | 9 | 33 | 22 | 32 | 309 |
| bta-miR-185 | 281 | 17 | 753 | 281 | 248 | 0 | 162 | 4171 |
| bta-miR-1 | 577 | 18 | 737 | 266 | 390 | 156 | 443 | 2146 |
| bta-miR-2284x | 618 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| bta-miR-125a | 301 | 5 | 834 | 212 | 392 | 0 | 436 | 0 |
| bta-miR-382 | 189 | 8 | 755 | 0 | 0 | 0 | 91 | 2431 |
| bta-miR-22-3p | 465 | 10 | 751 | 206 | 258 | 71 | 252 | 1409 |
| bta-miR-660 | 132 | 0 | 521 | 0 | 0 | 0 | 0 | 615 |
| bta-miR-100 | 29 | 1 | 692 | 31 | 32 | 22 | 32 | 309 |
| bta-miR-146a | 203 | 0 | 772 | 0 | 99 | 18 | 104 | 1858 |
| bta-miR-184 | 25 | 1 | 775 | 87 | 19 | 2 | 16 | 1425 |
Candidate target genes for differentially expressed miRNAs obtained by the intersection of at least three programs.
| miRNA name | Target gene | TG1 | NS2 |
|---|---|---|---|
| bta-miR-29b |
| 14 | 7 |
| bta-miR-29c |
| 19 | 6 |
| bta-miR-375 |
| 14 | 5 |
| bta-miR-135a |
| 16 | 6 |
| bta-miR-22-5p |
| 18 | 5 |
| bta-miR-214 |
| 9 | 6 |
| bta-miR-33a |
| 11 | 6 |
| bta-miR-451 |
| 13 | 3 |
| bta-miR-190a |
| 6 | 6 |
| bta-miR-378 |
| 9 | 3 |
| bta-miR-423-5p |
| 7 | 3 |
| bta-miR-7 |
| 13 | 6 |
| bta-miR-99a |
| 6 | 5 |
| bta-miR-185 |
| 19 | 5 |
| bta-miR-1 |
| 6 | 7 |
| bta-miR-125a |
| 6 | 5 |
| bta-miR-382 |
| 6 | 4 |
| bta-miR-22-3p |
| 13 | 6 |
| bta-miR-660 |
| 3 | 3 |
| bta-miR-100 |
| 10 | 5 |
| bta-miR-146a |
| 27 | 4 |
| bta-miR-184 |
| 7 | 4 |
1Total of genes that are selected as candidate target genes.
2The number of programs that can predict these candidate target genes.
Figure 2The annotated GO level distributions of three GO domains.
Figure 3GO classification of the target genes at level 2 that were annotated through Blast2GO.
The ten most enriched GO terms of target genes on all levels in the three domains.
| GO domain | GO ID | Term | TS1 | Score | GO level |
|---|---|---|---|---|---|
| Biological_process | GO: 0008150 | Biological process | 195 | 180.95 | 1 |
| GO: 0009987 | Cellular process | 185 | 136.79 | 2 | |
| GO: 0050794 | Regulation of cellular process | 150 | 98.57 | 4 | |
| GO: 0050789 | Regulation of biological process | 157 | 79.43 | 3 | |
| GO: 0032502 | Developmental process | 115 | 74.99 | 2 | |
| GO: 0048856 | Anatomical structure development | 103 | 72.83 | 3 | |
| GO: 0032501 | Multicellular organismal process | 126 | 62.86 | 2 | |
| GO: 0007275 | Multicellular organismal development | 106 | 62.29 | 3 | |
| GO: 0050896 | Response to stimulus | 123 | 62.25 | 2 | |
| GO: 0048731 | System development | 85 | 55.98 | 4 | |
|
| |||||
| Molecular_function | GO: 0005488 | Binding | 177 | 152.98 | 2 |
| GO: 0005515 | Protein binding | 149 | 148.21 | 3 | |
| GO: 0003674 | Molecular function | 190 | 126.3 | 1 | |
| GO: 0003677 | DNA binding | 51 | 40.89 | 4 | |
| GO: 0003676 | Nucleic acid binding | 72 | 40.37 | 3 | |
| GO: 0046872 | Metal ion binding | 59 | 36.02 | 5 | |
| GO: 0008270 | Zinc ion binding | 34 | 34 | 7 | |
| GO: 0003700 | Sequence-specific DNA-binding transcription factor activity | 33 | 28.16 | 3 | |
| GO: 0005524 | ATP binding | 25 | 25 | 8 | |
| GO: 0043169 | Cation binding | 59 | 21.61 | 4 | |
|
| |||||
| Cellular_component | GO: 0044464 | Cell part | 190 | 105.3 | 3 |
| GO: 0005737 | Cytoplasm | 129 | 90.45 | 5 | |
| GO: 0044424 | Intracellular part | 171 | 87.68 | 4 | |
| GO: 0005575 | Cellular component | 201 | 82.84 | 1 | |
| GO: 0044444 | Cytoplasmic part | 87 | 81.41 | 5 | |
| GO: 0005634 | Nucleus | 111 | 78.92 | 7 | |
| GO: 0043231 | Intracellular membrane-bounded organelle | 144 | 76.8 | 6 | |
| GO: 0005623 | Cell | 190 | 65.18 | 2 | |
| GO: 0043229 | Intracellular organelle | 154 | 62.49 | 5 | |
| GO: 0005622 | Intracellular | 175 | 57.61 | 4 | |
1The total of gene sequences that were annotated to this term.
Figure 4The expression pattern of miRNAs and the significantly enriched GO annotations of their target genes. The relative expression patterns of miRNAs among the three stages are shown on the left side, and the significantly enrichd GO terms of that cluster are shown on the right side. Every circle represents an miRNA expression pattern: (a) bta-miR-29b, bta-miR-29c, bta-miR-375, bta-miR-135a, bta-miR-22-5p, bta-miR-885, bta-miR-214, bta-miR-33a, bta-miR-451, and bta-miR-190a; (b) bta-miR-378, bta-miR-423-5p, and bta-miR-7; (c) bta-miR-22-3p, bta-miR-99a, and bta-miR-185; (d) bta-miR-1, bta-miR-2284x, bta-miR-125a, bta-miR-382, bta-miR-423-3p, bta-miR-660, and bta-miR-100; (e) bta-miR-146a and bta-miR-184. The order is given from inside to outside.
The KEGG pathways and annotated target genes.
| Pathway ID | Pathway | Related gene |
|---|---|---|
| bta05200 | Pathways in cancer |
|
| bta04510 | Focal adhesion |
|
| bta04810 | Regulation of actin cytoskeleton |
|
| bta04360 | Axon guidance |
|
| bta04144 | Endocytosis |
|
| bta04010 | MAPK signaling pathway |
|
| bta04512 | ECM-receptor interaction |
|
| bta04110 | Cell cycle |
|
| bta04722 | Neurotrophin signaling pathway |
|
| bta04012 | ErbB signaling pathway |
|
| bta04912 | GnRH signaling pathway |
|
| bta04114 | Oocyte meiosis |
|
| bta04260 | Cardiac muscle contraction |
|
| bta04350 | TGF-beta signaling pathway |
|
| bta05217 | Basal cell carcinoma |
|
| bta04370 | VEGF signaling pathway |
|
| bta05222 | Small cell lung cancer |
|
| bta04916 | Melanogenesis |
|
| bta05016 | Huntington's disease |
|
| bta04270 | Vascular smooth muscle contraction |
|
| bta04720 | Long-term potentiation |
|
| bta04530 | Tight junction |
|
| bta04660 | T cell receptor signaling pathway |
|
| bta04910 | Insulin signaling pathway |
|